Observatory · observe first
Follow the allocation change
Matched S&P 500 members → sector → industry → sub-industry → company. Each step uses the same percentage points.
Historical time machine
Historical observation
20182026
1 · Sector
Weight and 12M allocation change
2 · Industry
Inside Health Care
Life Sciences Tools & Services2.24%+0.50 ppPharmaceuticals5.03%-0.32 ppManaged Health Care2.11%+0.18 ppHealth Care Supplies0.27%+0.15 ppHealth Care Services0.84%-0.15 ppHealth Care Equipment3.48%+0.12 ppBiotechnology2.43%-0.06 ppHealth Care Facilities0.20%-0.04 ppHealth Care Distributors0.31%-0.03 ppHealth Care Technology0.00%+0.00 pp
3 · Sub-industry
Inside Biotechnology
Biotechnology · weight
2.43%
Industry change · 12M
-0.06 pp
Biotechnology · contribution
-0.055 pp
Company participation
100%
of industry constituents above their 6M weight average
4 · Companies driving this sub-industry
Oct 2020 · sorted by absolute contribution to 12-month change
| Company | Country | Market cap | Universe weight | 3M contribution | 12M contribution | 12M price return | Above 6M weight average |
|---|---|---|---|---|---|---|---|
| AbbVie → ABBV | United States | $150.2bn | 0.711% | +0.710 pp | +0.098 pp | +12.9% | Yes |
| Biogen → BIIB | United States | $38.8bn | 0.184% | +0.183 pp | -0.097 pp | -15.6% | Yes |
| Regeneron Pharmaceuticals → REGN | United States | $51.1bn | 0.242% | +0.242 pp | +0.092 pp | +77.5% | Yes |
| Gilead Sciences → GILD | United States | $72.9bn | 0.345% | +0.345 pp | -0.075 pp | -5.2% | Yes |
| Amgen → AMGN | United States | $126.3bn | 0.598% | +0.597 pp | -0.062 pp | +4.5% | Yes |
| Vertex Pharmaceuticals → VRTX | United States | $54.2bn | 0.257% | +0.256 pp | -0.005 pp | +6.6% | Yes |
| Incyte → INCY | United States | $18.9bn | 0.090% | +0.090 pp | -0.005 pp | +3.2% | Yes |
Company contributions use weights among matched S&P 500 members and add through each level without rescaling. Companies without matched shares and prices are omitted. These observations do not establish official index weights or actual fund flows.